Current market catalysts

Seaport Global Upgrades Asbury Automotive Group to Buy, Announces $300 Price Target

Seaport Global analyst Glenn Chin upgrades Asbury Automotive Group (NYSE:ABG) from Neutral to Buy and announces $300 price target.

What's Going On With SK Hynix Stock Tuesday?

SK Hynix (SKHY) stock rises amid an AI memory chip boom. Discover analyst ratings, supply shortage forecasts, and growth outlooks.

Hennessy Capital Investment's Combination Partner, One Nuclear Energy, Advanced Project Amberjack.

Project Amberjack moves into the next phase of development, including detailed technical and environmental reviews, and NRC engagement

JP Morgan Upgrades Cenovus Energy to Overweight, Raises Price Target to C$58

JP Morgan analyst Arun Jayaram upgrades Cenovus Energy (TSX:CVE) from Neutral to Overweight and raises the price target from C$51 to C$58.

8-K filing — Health Catalyst, Inc. (HCAT)

Filed: 2026-09-08 AccNo: 0001636422-26-000104 Size: 521 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

DigitalBridge, L&G And TD Greystone Announce Deal To Acquire VodafoneZiggo Towers, Combining With Belgium Tower Partners; Terms Not Disclosed, Expects Close In Early 2027

General Mills Reaffirms FY27 Organic Net Sales Target To Be Down 1.5% And Up 0.5%

General Mills reaffirmed its full-year financial targets for fiscal 20271:Organic net sales are expected to range between down 1.5 percent and up 0.5 percent.Adjusted operating profit is expected to be down 13 percent

Tamboran Resources Initiates Gas Sales From Its Shenandoah South Pilot Project In Beetaloo Basin

BMO Capital Downgrades BioNTech to Market Perform, Lowers Price Target to $105

BMO Capital analyst Evan Seigerman downgrades BioNTech (NASDAQ:BNTX) from Outperform to Market Perform and lowers the price target from $128 to $105.

U.S. Patent And Trademark Office Issues Lineage Cell Therapeutics U.S. Patent No. 12,692,476

OpenAI, Anthropic Seek Investment-Grade Ratings Post Potential IPOs to Cut AI Borrowing Costs: Report

OpenAI and Anthropic seek investment-grade ratings ahead of expected IPOs to lower borrowing costs and access broader debt markets.

GrafTech International Raises Prices By 30% For Graphite Electrode, Effective Immediately

GrafTech International Ltd. (NYSE:EAF) today announced that it has informed customers of a minimum increase of 30% in graphite electrode prices, effective immediately for all open commercial negotiations.The price

QNB Corp Announces Sale Of $254.4M In Book Value Of AFS Securities Yielding 1.59%, Unwind Of $162.0M Notional Pay-Fixed Swaps; Says Estimated Net Pre-Tax Loss Of About $26.2M In Q3 2026

JP Morgan Initiates Coverage On FedEx Freight Hldg Co with Overweight Rating, Announces Price Target of $160

JP Morgan analyst Brian Ossenbeck initiates coverage on FedEx Freight Hldg Co (NYSE:FDXF) with a Overweight rating and announces Price Target of $160.

Agilent's Independent Chair Koh Boon Hwe Retired, Effective Sept. 4, 2026.

8-K filing — Structure Therapeutics Inc. (GPCR)

Filed: 2026-09-08 AccNo: 0001104659-26-105688 Size: 7 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — OCEANEERING INTERNATIONAL INC (OII)

Filed: 2026-09-08 AccNo: 0000073756-26-000147 Size: 243 KB Item 7.01: Regulation FD Disclosure

Coya Therapeutics Announces Publication Of Preclinical Results For COYA 303 In International Journal Of Molecular Sciences; Results Show Complementary Immunomodulatory Effects In Peripheral And CNS Inflammation

Study results showed complementary immunomodulatory effects of COYA 303, a combination of proprietary low-dose IL-2 (LD-IL2) and a GLP-1 Receptor Agonist (GLP-1RA), compared to either LD-IL2 or GLP-1RA as

Quantum Announces Release Of Autonomous Data Management Solution

GE HealthCare Says StarGuide GX 4D CZT SPECT/CT System Is 510(k) Pending With FDA Following CE Mark

8-K filing — PATTERSON UTI ENERGY INC (PTEN)

Filed: 2026-09-08 AccNo: 0000889900-26-000065 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Intellia Therapeutics Announces FDA Acceptance For Its Biologics License Application For Ionvo-Z; FDA Sets March 10, 2027, As PDUFA Date

Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced the U.S. Food and Drug

Hyperion DeFi Announces New $20M Buyback Program, In Place For Up To 12 Months

Hyperion DeFi Raises FY2026 Adjusted Gross Profit Guidance To $7M-$8M From $5M-$7M; Expects Positive Core Operating Earnings And Adjusted Net Operating Cash Flow In Q3 2026

OFA Group Launches PlanAId, AI-Powered Blueprint Review Platform To Help AEC Professionals Identify Building-Code Issues Early in Development

New platform enables architects, engineers, and construction professionals to identify potential building code issues before plans reach formal review Torrance, CA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Building code

BioAge Labs Doses First Patient In Its Phsae 2 Study Of BGE-102 To Treat Diabetic Macular Edema

BioAge Labs, Inc. (Nasdaq: BIOA) ("BioAge" or the "Company"), a clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of

Structure Therapeutics Says Aleniglipron Achieved Up To 16.2% Weight Loss At 72 Weeks In ACCESS Open-Label Extension With No Plateau; Says Phase 1/2a ACCG-2671 SAD Trial Showed 3.3% Weight Loss

Spyre's SPY003 Met Its Primary Endpoint

SPY003 met its primary endpoint with a statistically significant reduction of 10.0 points (p<0.0001) from baseline at Week 12 in Robart’s Histopathology Index (RHI) score Secondary endpoints included clinical

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Gainers GMEX Robotics (NASDAQ:GMEX) stock increased by 14.8% to $0.85 during Tuesday's pre-market session. Crown Crafts (NASDAQ:CRWS) stock increased by 10.29% to $3.0. The market value of their outstanding shares

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by